Retour
Fourchette du Jour
17,95 €
20,37 €
Fourchette 52 Semaines
15,08 €
21,08 €
Volume
50
Moyenne 50J / 200J
19,28 €
/
17,74 €
Clôture Précédente
20,37 €
Quick Summary
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (633 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | 0,4 | 0,2 |
| P/B | 0,0 | 2,8 |
| ROE % | 8,4 | 3,7 |
| Net Margin % | 10,6 | 3,9 |
| Rev Growth 5Y % | 18,2 | 9,7 |
| D/E | 0,1 | 0,2 |
Objectif de Cours des Analystes
Aucune couverture d'analyste disponible
Estimations de Bénéfices
| Période | BPA Est. | CA Est. | Analystes |
|---|---|---|---|
| FY2030 |
1,00 €
0,92 € – 1,06 €
|
189,60B | 1 |
| FY2029 |
0,89 €
0,82 € – 0,95 €
|
172,18B | 1 |
| FY2028 |
0,84 €
0,78 € – 0,89 €
|
164,26B | 1 |
No quarterly estimates available
Earnings Surprises
Last 8 quarters
| Quarter | Est. EPS | Actual EPS | Surprise |
|---|---|---|---|
| 2026-02-13 | 0,15 € | 0,19 € | +27,7% |
| 2025-11-12 | 0,17 € | 0,23 € | +33,6% |
| 2025-08-12 | 0,07 € | 0,10 € | +43,4% |
| 2025-05-13 | 0,14 € | -0,09 € | -164,5% |
| 2025-02-12 | 0,12 € | 0,13 € | +9,8% |
| 2024-11-14 | 0,15 € | 0,17 € | +12,8% |
| 2024-08-14 | 0,05 € | 0,04 € | -13,5% |
| 2024-05-15 | 0,11 € | 0,10 € | -9,2% |
Dividend History
7 yr streakYield
0,01%
Payout Ratio
0,43%
Growth (3Y)
24,13%
Growth (5Y)
15,49%
| Ex-Date | Payment Date | Amount | Yield |
|---|---|---|---|
| Jun 30, 2026 | — | 0,23 € | 1,13% |
| Jun 30, 2025 | Sep 26, 2025 | 0,17 € | 0,95% |
| Jun 28, 2024 | Sep 27, 2024 | 0,13 € | 0,67% |
| Jun 29, 2023 | Sep 29, 2023 | 0,10 € | 0,53% |
| Jun 29, 2022 | Sep 30, 2022 | 0,09 € | 0,57% |
| Jun 29, 2021 | Sep 30, 2021 | 0,10 € | 0,23% |
| Jun 29, 2020 | Sep 30, 2020 | 0,08 € | 0,18% |
| Jun 26, 2019 | Sep 30, 2019 | 0,20 € | 0,43% |
| Jun 27, 2018 | Sep 28, 2018 | 0,18 € | 0,39% |
| Jun 28, 2017 | Sep 27, 2017 | 0,27 € | 0,36% |
| Jun 28, 2016 | Sep 29, 2016 | 0,29 € | 0,36% |
| Jun 26, 2015 | Sep 30, 2015 | 0,37 € | 0,31% |
| Jun 26, 2014 | Sep 29, 2014 | 0,33 € | 0,23% |
| Jun 26, 2013 | Sep 27, 2013 | 0,48 € | 0,16% |
| Jun 27, 2012 | Sep 28, 2012 | 0,25 € | 0,07% |
| Jun 28, 2011 | Sep 30, 2011 | 0,42 € | 0,11% |
| Jun 28, 2010 | Sep 30, 2010 | 0,28 € | 0,07% |
| Jun 25, 2009 | Sep 30, 2009 | 0,08 € | 0,02% |
| Jun 25, 2008 | Sep 29, 2008 | 0,16 € | 0,04% |
| Jun 26, 2007 | Sep 28, 2007 | 0,14 € | 0,04% |
Points Clés
Revenue grew 18,19% annually over 5 years — strong growth
Earnings declined -19,43% over the past year
Debt/Equity of 0,07 — conservative balance sheet
Generating 31,97B in free cash flow
P/E of 0,42 — trading at a low valuation
Revenue growth is decelerating — 1Y growth trails 5Y average by 6,59%
Croissance
Revenue Growth (5Y)
18,19%
Revenue (1Y)11,60%
Earnings (1Y)-19,43%
FCF Growth (3Y)123,05%
Qualité
Return on Equity
8,44%
ROIC13,96%
Net Margin10,61%
Op. Margin25,06%
Sécurité
Debt / Equity
0,07
Current Ratio3,71
Interest Coverage140,56
Valorisation
P/E Ratio
0,42
Forward P/E29,24
P/B Ratio0,04
EV/EBITDA-1,25
Dividend Yield0,01%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 11,60% | Revenue Growth (3Y) | 15,42% |
| Earnings Growth (1Y) | -19,43% | Earnings Growth (3Y) | -1,42% |
| Revenue Growth (5Y) | 18,19% | Earnings Growth (5Y) | 6,28% |
| Profitability | |||
| Revenue (TTM) | 120,03B | Net Income (TTM) | 12,74B |
| ROE | 8,44% | ROA | 6,59% |
| Gross Margin | 67,68% | Operating Margin | 25,06% |
| Net Margin | 10,61% | Free Cash Flow (TTM) | 31,97B |
| ROIC | 13,96% | FCF Growth (3Y) | 123,05% |
| Safety | |||
| Debt / Equity | 0,07 | Current Ratio | 3,71 |
| Interest Coverage | 140,56 | ||
| Dividends | |||
| Dividend Yield | 0,01% | Payout Ratio | 0,43% |
| Dividend Growth (3Y) | 24,13% | Dividend Growth (5Y) | 15,49% |
| Consecutive Div Years | 7 yrs | ||
| Valuation | |||
| P/E Ratio | 0,42 | Forward P/E | 29,24 |
| P/B Ratio | 0,04 | P/S Ratio | 0,05 |
| PEG Ratio | -2,56 | Forward PEG | N/A |
| EV/EBITDA | -1,25 | Fwd EV/EBITDA | -0,96 |
| Forward P/S | 0,04 | Fwd Earnings Yield | 3,42% |
| FCF Yield | 591,43% | ||
| Market Cap | 5,40B | Enterprise Value | -37,70B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 120,03B | 107,55B | 90,10B | 77,75B | 61,51B |
| Net Income | 12,74B | 15,81B | 13,11B | 10,86B | 9,98B |
| EPS (Diluted) | 46,92 | 58,20 | 48,25 | 40,00 | 38,07 |
| Gross Profit | 81,24B | 69,05B | 58,83B | 51,08B | 41,47B |
| Operating Income | 30,08B | 22,14B | 18,03B | 15,24B | 12,80B |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 193,19B | 191,61B | 172,64B | 155,13B | 115,43B |
| Total Liabilities | 41,84B | 39,66B | 38,35B | 34,00B | 22,49B |
| Shareholders' Equity | 150,56B | 151,21B | 132,31B | 119,46B | 92,91B |
| Total Debt | 11,10B | 6,70B | 14,25B | 12,18B | 8,04B |
| Cash & Equivalents | 54,20B | 35,66B | 34,88B | 32,32B | 21,36B |
| Current Assets | 103,36B | 94,70B | 90,26B | 79,61B | 61,13B |
| Current Liabilities | 27,86B | 29,49B | 26,32B | 20,76B | 14,67B |
Scores de Stratégies
This stock passed the criteria for 3 strategies
Score = fit strength (0–100)
Rank = position among all matches
Activité Récente
Sorti
Defensive Investing (Benjamin Graham)
Mar 26, 2026
Entré
Cash Flow Compounder
Mar 24, 2026
Entré
Deep Value Investing (Seth Klarman)
Mar 24, 2026
Entré
Price/Sales Ratio Focus (Ken Fisher)
Mar 24, 2026
Entré
Defensive Investing (Benjamin Graham)
Mar 24, 2026